• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Menomune-A/C/Y/W-135

STN: BL 103926       
Proper Name: Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W135 Combined
Tradename: Menomune-A/C/Y/W-135
Manufacturer: Sanofi Pasteur Inc, License #1725
Indication:  

  • For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older.

 

 

-

Supporting Documents

-
 

Contact FDA

(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

1401 Rockville Pike

Suite 200N/HFM-47

Rockville, MD 20852-1448